US medical device giant Edwards Lifesciences has said patients are experiencing “outstanding one-year outcomes” and lower ...

Data from randomized trials examining whether early intervention with transcatheter aortic ... stenosis to undergo early TAVR with transfemoral placement of a balloon-expandable valve or clinical ...

Boston Scientific (NYSE:BSX) shared data highlighting the safety and efficacy of its Acurate Prime XL aortic valve system.

Hemodynamic obstruction (stenosis) appears when more than half of its normal area is lost and clinical ... of valve interstitial cells into an osteoblast phenotype, which causes aortic valve ...

The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and ...

The results of a new clinical trial have overturned the ... could change the way doctors treat severe aortic stenosis, a narrowing of the valve that controls blood flow from the heart.

Early transcatheter aortic valve replacement bests clinical ... severe aortic stenosis, according to a study published online in the New England Journal of Medicine. The research was published ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

today announced the results of the primary endpoint of the ACURATE IDE clinical trial, which evaluated the ACURATE neo2™ Aortic Valve System in the treatment of patients with severe ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...